Table 1. Patient Characteristics (N=33).
| No. | % | |
|---|---|---|
| Male | 28 | 85 |
| Age, years | ||
| Mean | 67 | |
| Range | 48-82 | |
| ECOG performance status | ||
| 0 | 15 | 45 |
| 1 | 15 | 45 |
| 2 | 3 | 10 |
| Histology | ||
| Transitional cell | 29 | 88 |
| Mixed | 4 | 12 |
| Site of primary tumor | ||
| Bladder | 29 | 88 |
| Other(ureter or renal pelvis) | 4 | 12 |
| No. of metastatic sites involved | ||
| 1 | 10 | 30 |
| 2 | 11 | 33 |
| 3 or more | 12 | 37 |
| Visceral metastases | ||
| Hepatic | 14 | 42 |
| Non-hepatic | 13 | 40 |
| Prior therapy | ||
| Adjuvant chemotherapy | 9 | 27 |
| Chemotherapy for advanced disease | 31 | 94 |
| Radiation therapy | 13 | 39 |
| Prior radical cystectomy | 15 | 45 |
| Previous platinum response | 18 | 55 |
Abbreviation:ECOG, Eastern Cooperative Oncology Group.